Published Date: 22-01-2018
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Dialysis Market, published by KBV research, the LAMEA Dialysis Market would witness market growth of 6.5% CAGR during the forecast period (2018 – 2024).
The Hemodialysis market would dominate the LAMEA Dialysis Market by Type by 2024, growing at a CAGR of 5.8 % during the forecast period. The Peritoneal Dialysis market is expected to witness a CAGR of 7.8% during (2018 - 2024).
The Brazil market dominated the LAMEA Services Market by Country in 2017. The Argentina market is expected to witness a CAGR of 6.6% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 4.6% during (2018 - 2024).
The In-center Dialysis market dominated the UAE Dialysis Market by End User in 2017, and would achieve a market value of $1,458.5 million by 2024, growing at a CAGR of 5 % during the forecast period. Additionally, The Home Dialysis market is expected to witness highest CAGR of 6.4% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/lamea-dialysis-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fresenius Medical Care Ag & Co. Kgaa, Baxter International, Inc., Davita Inc., Nipro Corporation, B. Braun Avitum Ag, Diaverum Deutschland Gmbh., Nikkiso Co. Ltd., Nxstage Medical, Inc., Cantel Medical Corporation (Medicators, Inc)., Asahi Kasei Corporation.
By End User
By Products & Services
Unique Offerings from KBV Research